Olr74 inhibitors represent a fascinating class of chemicals, primarily studied for their ability to selectively interact with and inhibit the activity of the Olr74 receptor. Olr74 is an olfactory receptor, part of the large G protein-coupled receptor (GPCR) family, which plays a crucial role in the detection of odor molecules. Inhibitors of Olr74 are designed to bind to the receptor with high affinity, blocking the binding of natural ligands or odorants, thereby modulating the receptor's signaling pathways. These inhibitors often exhibit complex structural characteristics that allow for precise interaction with the receptor's binding site, and their synthesis involves intricate organic chemistry techniques. By exploring the binding interactions between Olr74 inhibitors and their target receptor, researchers gain valuable insights into the structural and functional dynamics of olfactory receptors.
The study of Olr74 inhibitors encompasses a range of sophisticated analytical methods, including X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and molecular docking simulations. These techniques enable scientists to visualize the molecular interactions at an atomic level, elucidating the conformational changes and binding affinities involved. Moreover, the development of these inhibitors often involves iterative cycles of rational design and synthesis, guided by computational modeling and structure-activity relationship (SAR) studies. By systematically modifying the chemical structure of potential inhibitors, researchers can optimize their binding efficiency and selectivity. The research surrounding Olr74 inhibitors not only advances our understanding of olfactory receptor functionality but also contributes to broader fields such as biochemistry and molecular biology, offering insights into GPCR signaling mechanisms and ligand-receptor interactions.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
MEK inhibitor, may affect MAPK/ERK pathway, indirectly influencing Olr74 signaling. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
AKT inhibitor, could modify AKT pathway potentially involved in Olr74 regulation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor, possibly influencing cell growth pathways that affect Olr74 activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor, may alter stress response pathways related to Olr74. | ||||||
LY3214996 | 1951483-29-6 | sc-507299 | 5 mg | $265.00 | ||
ERK1/2 inhibitor, could impact pathways connected to Olr74 function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor, potentially modifying JNK signaling pathways influencing Olr74. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
NF-κB inhibitor, might affect inflammatory signaling pathways related to Olr74. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Src family kinase inhibitor, may impact kinases associated with Olr74 signaling. | ||||||
BYL719 | 1217486-61-7 | sc-391001 sc-391001A sc-391001B sc-391001C sc-391001D sc-391001E | 5 mg 10 mg 50 mg 100 mg 500 mg 1 g | $391.00 $597.00 $755.00 $1192.00 $5000.00 $9370.00 | 2 | |
PI3K inhibitor, could alter PI3K/AKT/mTOR signaling linked to Olr74. | ||||||
AZD8055 | 1009298-09-2 | sc-364424 sc-364424A | 10 mg 50 mg | $163.00 $352.00 | 12 | |
mTORC1/2 inhibitor, potentially influencing pathways that regulate Olr74. | ||||||